ATH 0.00% 0.5¢ alterity therapeutics limited

Ann: US FDA Approval for IND Application for ATH434 for MSA, page-14

  1. 633 Posts.
    lightbulb Created with Sketch. 41
    I feel for everyone who bought in on yesterday's news. I don't think it's a pump and dump, it's just that we are looking at a year-long trial, so there won't be anything meaningful to excite the market for quite some time. I predict a continued slow decline of the share price for another six months at least.
    (now watch the market price me wrong!)
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.